What is already known about this subject:
- Iptakalim is a selective KATP channel opener exerting the blood
pressure-lowering effect.
- Cardiotoxicity has been one of the most common causes for withdrawing
drugs from the market.
- ER analysis has been recommended for the estimation of QT interval
prolongation risks of drugs in appropriate research.